Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio cash
Cash and short-term investments held at the end of each period.
Palisade Bio's cash was $125.17M at Jun 30, 2026. For fiscal 2025 it was $133.39M, up 1258.2% from the year before. Over ten years it grew 27.0% a year on average. The highest annual figure on record is $133.39M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $133.39M | +1258.2% |
| FY2024 | Dec 31, 2024 | $9.82M | -21.0% |
| FY2023 | Dec 31, 2023 | $12.43M | +0.4% |
| FY2022 | Dec 31, 2022 | $12.38M | +18.0% |
| FY2021 | Dec 31, 2021 | $10.50M | +1371.9% |
| FY2020 | Dec 31, 2020 | $713.00K | -86.1% |
| FY2019 | Dec 31, 2019 | $5.11M | -11.6% |
| FY2018 | Dec 31, 2018 | $5.79M | -50.5% |
| FY2017 | Dec 31, 2017 | $11.70M | -42.1% |
| FY2016 | Dec 31, 2016 | $20.20M | +65.1% |
| FY2015 | Dec 31, 2015 | $12.23M | -55.6% |
| FY2014 | Dec 31, 2014 | $27.53M | +63.4% |
| FY2013 | Dec 31, 2013 | $16.85M | +126.3% |
| FY2012 | Dec 31, 2012 | $7.44M | +216.5% |
| FY2011 | Dec 31, 2011 | $2.35M | -74.6% |
| FY2010 | Dec 31, 2010 | $9.26M | +301.0% |
| FY2009 | Dec 31, 2009 | $2.31M | -52.9% |
| FY2008 | Dec 31, 2008 | $4.90M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $125.17M | +2210.7% |
| Q1 FY2026 | Mar 31, 2026 | $132.63M | +1734.4% |
| Q4 FY2025 | Dec 31, 2025 | $133.39M | +1258.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.23M | -35.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.42M | -52.3% |
| Q1 FY2025 | Mar 31, 2025 | $7.23M | -35.9% |
| Q4 FY2024 | Dec 31, 2024 | $9.82M | -21.0% |
| Q3 FY2024 | Sep 30, 2024 | $8.04M | -47.5% |
| Q2 FY2024 | Jun 30, 2024 | $11.35M | -30.8% |
| Q1 FY2024 | Mar 31, 2024 | $11.28M | -15.2% |
| Q4 FY2023 | Dec 31, 2023 | $12.43M | +0.4% |
| Q3 FY2023 | Sep 30, 2023 | $15.31M | +9.5% |
| Q2 FY2023 | Jun 30, 2023 | $16.40M | +229.4% |
| Q1 FY2023 | Mar 31, 2023 | $13.30M | +100.1% |
| Q4 FY2022 | Dec 31, 2022 | $12.38M | +18.0% |
| Q3 FY2022 | Sep 30, 2022 | $13.99M | -0.8% |
| Q2 FY2022 | Jun 30, 2022 | $4.98M | -60.6% |
| Q1 FY2022 | Mar 31, 2022 | $6.64M | +980.3% |
| Q4 FY2021 | Dec 31, 2021 | $10.50M | +1371.9% |
| Q3 FY2021 | Sep 30, 2021 | $14.10M | +1778.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.65M | +733.0% |
| Q1 FY2021 | Mar 31, 2021 | $615.00K | -93.9% |
| Q4 FY2020 | Dec 31, 2020 | $713.00K | -86.1% |
| Q3 FY2020 | Sep 30, 2020 | $751.00K | -89.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.52M | -33.4% |
| Q1 FY2020 | Mar 31, 2020 | $10.03M | +150.4% |
| Q4 FY2019 | Dec 31, 2019 | $5.11M | -11.6% |
| Q3 FY2019 | Sep 30, 2019 | $7.30M | +27.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.28M | -67.8% |
| Q1 FY2019 | Mar 31, 2019 | $4.01M | -58.8% |
| Q4 FY2018 | Dec 31, 2018 | $5.79M | -50.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.74M | -59.3% |
| Q2 FY2018 | Jun 30, 2018 | $7.09M | -37.8% |
| Q1 FY2018 | Mar 31, 2018 | $9.72M | -41.8% |
| Q4 FY2017 | Dec 31, 2017 | $11.70M | -42.1% |
| Q3 FY2017 | Sep 30, 2017 | $14.10M | +147.4% |
| Q2 FY2017 | Jun 30, 2017 | $11.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $16.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.20M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.70M | – |
See a number that looks wrong?